Form 4: Vertex Pharmaceuticals CFO Sells 3,000 Shares Under Pre-Arranged Trading Plan

Charles F. Wagner Jr., EVP & Chief Financial Officer of Vertex Pharmaceuticals, sold 3,000 shares of common stock at $518.27 per share under a pre-arranged trading plan.

Summary

• Charles F. Wagner Jr., the EVP & Chief Financial Officer of Vertex Pharmaceuticals, sold 3,000 shares of the company's common stock.
• The sale occurred on November 11, 2024, at a price of $518.27 per share.
• This transaction was executed under a pre-arranged trading plan established on August 8, 2024, in accordance with Rule 10b5-1.
• Following the transaction, Mr. Wagner directly owns 44,137 shares of Vertex Pharmaceuticals common stock.

Sentiment

Score: 5

Explanation: The document is a routine SEC filing regarding an executive's stock sale under a pre-arranged plan. It does not indicate any positive or negative sentiment about the company's performance.

Industry Context

This is a routine filing related to insider trading activity. It is common for executives to use pre-arranged trading plans to avoid accusations of trading on inside information.

Comparison to Industry Standards

• Rule 10b5-1 trading plans are a common practice among executives at publicly traded companies to manage their personal finances while avoiding potential conflicts of interest.
• The sale of 3,000 shares is a relatively small transaction compared to the overall market capitalization of Vertex Pharmaceuticals and is unlikely to have a significant impact on the stock price.
• Other pharmaceutical companies such as Gilead Sciences (GILD) and Amgen (AMGN) also see similar filings from their executives.

Stakeholder Impact

• The sale of shares by an executive may be perceived negatively by some shareholders, but the pre-arranged nature of the sale mitigates this concern.
• The impact on other stakeholders is likely to be minimal.

Key Dates

Keywords

Vertex Pharmaceuticals, VRTX, insider trading, stock sale, Rule 10b5-1, Charles F. Wagner Jr., CFO, executive transaction